SCHEMBL6545188

SCHEMBL6545188

NC/C=C/CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6544665 1.00
SCHEMBL3134391 0.84 CYP2D6 (1.00)
SCHEMBL28168136 0.84 CYP2D6 (1.00)
SCHEMBL190067 0.84 CYP2D6 (1.00)
SCHEMBL213024 0.84 CYP2D6 (1.00)
Ammonia Solution, Strong SCHEMBL25317379 0.81 CYP2D6 (0.92)
Hydrochloric Acid SCHEMBL10880042 0.81 CYP2D6 (0.92)
Ammonia Solution, Strong SCHEMBL25317376 0.81 CYP2D6 (0.92)
SCHEMBL16853126 0.79 GABRR1 (0.46)
SCHEMBL27578511 0.79 GABRR1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043755-B2 Compositions, methods, and articles relating to in-situ crosslinking of polyamides during additive manufacturing XEROX CORPORATION (US) 2024-07-23 US disclosed
US-12043755-B2 Compositions, methods, and articles relating to in-situ crosslinking of polyamides during additive manufacturing XEROX CORPORATION (US) 2024-07-23 US disclosed
EP-4006080-A1 COMPOSITIONS, METHODS, AND ARTICLES RELATING TO IN-SITU CROSSLINKING OF POLYAMIDES DURING ADDITIVE MANUFACTURING Xerox Corporation (US) 2022-06-01 EP disclosed
US-20220162474-A1 COMPOSITIONS, METHODS, AND ARTICLES RELATING TO IN-SITU CROSSLINKING OF POLYAMIDES DURING ADDITIVE MANUFACTURING XEROX CORPORATION (US) 2022-05-26 US disclosed
US-20210188914-A1 HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF THE JOHNS HOPKINS UNIVERSITY 2021-06-24 US disclosed
US-10954273-B2 Hybrid cyclic libraries and screens thereof THE JOHNS HOPKINS UNIVERSITY (US) 2021-03-23 US disclosed
US-20190389911-A1 HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF THE JOHNS HOPKINS UNIVERSITY 2019-12-26 US disclosed
US-10414801-B2 Hybrid cyclic libraries and screens thereof THE JOHNS HOPKINS UNIVERSITY (US) 2019-09-17 US disclosed
US-20180222942-A1 HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF THE JOHNS HOPKINS UNIVERSITY 2018-08-09 US disclosed
US-20180222942-A1 HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF THE JOHNS HOPKINS UNIVERSITY 2018-08-09 US disclosed
US-9250237-B2 Hybrid cyclic libraries and screens thereof THE JOHNS HOPKINS UNIVERSITY (US) 2016-02-02 US disclosed
US-9250237-B2 Hybrid cyclic libraries and screens thereof THE JOHNS HOPKINS UNIVERSITY (US) 2016-02-02 US disclosed
US-20140073581-A1 Hybrid Cyclic Libraries and Screens Thereof THE JOHNS HOPKINS UNIVERSITY 2014-03-13 US disclosed
US-20140073581-A1 Hybrid Cyclic Libraries and Screens Thereof THE JOHNS HOPKINS UNIVERSITY 2014-03-13 US disclosed
EP-0931792-B1 Depsipeptides containing non-natural amino acids NISSHIN SEIFUN GROUP INC (JP) 2004-01-07 EP disclosed
US-6288038-B1 ACCELERATE APOLIPOPROTEIN E PRODUCTION; NERVOUS SYSTEM DISORDERS, ALZHEIMER*S DISEASE; ANTILIPEMIC AGENTS NISSHIN SEIFUN GROUP INC. (JP) 2001-09-11 US disclosed
US-6252041-B1 Depsipeptides containing non-natural amino acids NISSHIN FLOUR MILLING CO., LTD. (JP) 2001-06-26 US disclosed
EP-1028126-A1 DEPSIPEPTIDE DERIVATIVES BEARING PIPERAZINONE RINGS Nisshin Flour Milling Co., Ltd. (JP) 2000-08-16 EP disclosed
EP-0931792-A1 Depsipeptides containing non-natural amino acids Nisshin Flour Milling Co., Ltd. (JP) 1999-07-28 EP disclosed
WO-1995023811-A1 NOVEL CARBOCYCLIC COMPOUNDS WHICH INHIBIT PLATELET AGGREGATION BY INTERACTION WITH THE GPIIB/IIIA RECEPTOR COMPLEX THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-09-08 WO disclosed